Regeneron Pharmaceuticals, Inc. (FRA:RGO)
535.60
+40.00 (8.07%)
At close: May 2, 2025, 10:00 PM CET
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €56.43 billion as of May 2, 2025. Its market cap has decreased by -38.00% in one year.
Market Cap
56.43B
Enterprise Value
43.28B
Revenue
13.03B
Ranking
n/a
PE Ratio
13.56
Stock Price
€535.60
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 56.43B, an increase of 42,845.19%. That is a compound annual growth rate of 20.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 297.83B |
Siemens Aktiengesellschaft | 157.90B |
Deutsche Telekom AG | 154.34B |
Allianz SE | 140.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 78.59B |
Rheinmetall AG | 65.11B |
Siemens Energy AG | 53.37B |
Merck KGaA | 53.00B |